What Has Been the Growth Trajectory of the Dog Vaccines Market?
The dog vaccines market has seen considerable growth due to a variety of factors.
• Recent years have seen a robust growth in the size of the dog vaccines market. The market is set to expand from $3.61 billion in 2024 to $3.81 billion in 2025, with a projected compound annual growth rate (CAGR) of 5.5%. The rise in the historic period can be attributed to factors such as innovative vaccination policies, increased awareness of zoonotic diseases, globalization and travel, educational campaigns, research and the development of new vaccines, as well as advancements in veterinary practices.
How Does the Forecast Look for the Dog Vaccines Market Size In The Coming Years?
The Dog Vaccines market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a substantial expansion is predicted in the dog vaccines market. The market is projected to reach $5.08 billion by 2029, fueled by a compound annual growth rate (CAGR) of 7.5%.
This anticipated growth could be due to factors such as the rise in adoption of pets, greater awareness of pet health among owners, government directives and guidelines, increasing tendency to humanize pets, and the occurrence of dog-related illnesses. Key trends expected during this growth period are pet insurance and healthcare programs, improved access and availability, personalized vaccination regimes, shifts in disease patterns, and the development of innovative vaccines.
What Are The Leading Drivers Of Growth In The Dog Vaccines Market?
The anticipated surge in pet dog ownership is predicted to boost the dog vaccines market in the future. The term 'pet dog' refers to a domesticated or tamed animal that lives in a household. A dog vaccine is an inoculation administered to dogs in a sequence starting from their puppy stage and continuing into their mature years. This vaccine sparks the immune system, aiding dogs in combating microorganisms without falling ill or experiencing severe symptoms. For example, the 2021-2022 National Pet Owners Survey by the US-based non-profit industry association, the American Pet Products Association, reported that 70% of American households, equivalent to 90.5 million homes, had a pet. Of this figure, 69 million U.S. homes owned a dog, the highest number compared to pets of other species. Therefore, the uptick in pet dog ownership is fuelling the expansion of the dog vaccines market.
How Are The Segments Defined Within The Global Dog Vaccines Market?
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine
Pre-Book The Dog Vaccines Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Dog Vaccines Market?
The surge in technological progress is a major trend capturing attention in the market for dog vaccines. Top-tier companies in this market are transitioning to innovative technology for the creation of vaccines. For instance, in September 2022, Nobivac Intra-Trac Oral BbPi was launched by Merck Animal Health, a company from the US that offers veterinary pharmaceuticals, vaccines, and tech solutions. This is the first oral vaccine featuring mucosal protection and easy oral administration. It's intended for the vaccination of healthy dogs over 7 weeks old, protecting them from canine parainfluenza virus and Bordetella bronchiseptica. Moreover, it incorporates a groundbreaking technology named Immuno-Mist-R, developed by Intervet, a subsidiary of Merck & Co. The use of this novel technology, Immuno-Mist-RTM, significantly extends the contact with the mucosal surface area.
Who Are the Key Players In The Dog Vaccines Market?
Major companies operating in the dog vaccines market include:
• Vetoquinol S.A.
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Heska Corporation
• Merck & Co. Inc.
• Virbac Animal Health Pvt. Ltd.
• Elanco Animal Health Incorporated
• Zoetis Inc.
• CZ Vaccines
• Indian Immunologicals Ltd.
• Meiji Holdings Co. Ltd.
• Bioveta A.S.
• Phibro Animal Health Corporation
• Hester Biosciences Limited
• High Speed Digieal Processor Architecture Pvt. Ltd.
• Dechra Pharmaceuticals PLC
• Norbrook Inc.
• Biogenesis Bago SA
• Vaxxinova India Private Limited
• Bimeda Animal Health Ltd.
• Lohmann Animal Health GmbH
• Biovac Ltd.
• Zenex Animal Health India Pvt. Ltd.
• Instituto Rosenbusch S A
What Is The Most Dominant Region In The Dog Vaccines Market?
Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
